Aim: Investigation whether the signal intensity of hepatocellular carcinoma (HCC) on dynamic magnetic resonance imaging (MRI) with hepatocellular contrast medium (CM) correlates with the histologic malignancy grade and cytometric DNA index. Material and Methods: MRI at 1.5 T with hepatocellular CM Gd-DTPA-EOB of 63 patients (52 men, 11 women; 64.0 ± 8.5 years) with HCC in cirrhosis. SI of the tumor and liver tissue in sequences (T1, T1fs, T2fs, T1fs + CM (arterial, venous, late venous phase) were correlated like the asymmetry coefficient of the SI in the arterial and venous phases respective the native and late venous phases of the tumor with the histologic malignancy grade and DNA index indicating the grade of abnormal DNA steam line respective aneuploid DNA. Results: SI did not significantly correlate with the histologic malignancy grade or DNA index for precontrast or postcontrast images. There is a significant correlation for the asymmetry coefficient of the SI in the arterial and venous phases with the DNA-index (p values of 0.00089 (Pearson) and 0.0082 (Spearman). Conclusion: A highly arterialized hepatocellular carcinoma with rapid washout in the venous phase corresponds to a higher malignant potential. These findings suggest that the MR parameters investigated here may predict the malignant potential and prognosis of HCC before surgery.
Introduction
Magnetic resonance imaging (MRI) with contrast medium is currently the best imaging modality for the detection and characterization of hepatocellular carcinoma (HCC) [1, 2] . It is based on the signal enhancement pattern after administration of contrast medium, particularly extracellular or tissue-specific hepatobiliary agents [2] . Gd-EOB-DTPA (Primovist ® , Bayer Healthcare, Berlin, Germany) is an MR contrast agent combining the properties of extracellular and hepatocellular agents. This means that images can be acquired both in the dynamic phase when the contrast agent is still in the intravascular space and in the hepatobiliary phase when the agent is metabolized by the hepatocytes. Accumulation in heaptocytes occurs within a few minutes of injection, enabling clear delineation of a HCC from healthy liver tissue.
Dynamic MRI with a fast T1-weighted gradient echo sequence obtained during the arterial (Figure 1 ), portal venous (Figure 2) , and late venous phases (Figure 3 ) after intravenous bolus administration of the contrast medium has been shown to be useful for characterizing HCC, which typically exhibits early arterial enhancement because it is highly arterialized [3] . Accumulation of contrast medium indicates a tumor of hepatocellular origin. In the routine clinical setting, however, differentiation of HCC from regenerative nodules in the cirrhotic liver continues to pose a challenge. In general, though, the use of morphologic imaging criteria allows adequate characterization of an intrahepatic tumor, and histologic confirmation of the diagnosis of HCC is generally not necessary before surgery. Accurate diagnostic characterization and differentiation of a malignant liver tumor is done using histologic grading or DNA cytometry. The latter may have important implications for treatment as it enables objective and reliable grading of the malignant potential. Photometric DNA measurement is based on the quantitative determination of the DNA content of cell nuclei [4] . The material for DNA analysis can be obtained by fine needle aspiration and may provide important additional information on the biologic behavior of a tumor that may alter the therapeutic strategy and determines the prognosis. Tumor cells are characterized by numerical and/or structural chromosome aberrations. Severe chromosomal aberration identified as significant by DNA cytometry is referred to as DNA aneuploidy and is an indicator of the malignant potential of a tumor. Hence, DNA ploidy or the DNA index has been identified to be an important prognostic indicator in patients who underwent liver transplantation because of HCC in cirrhosis [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] .
Jonas et al. showed DNA ploidy to be a useful prognostic factor in patients who received a liver transplant for HCC in cirrhosis, demonstrating that its predictive value is superior to tumor staging. In this study, aneuploidy, or a high DNA index, indicated a poorer prognosis in liver transplant recipients than diploid and polyploid carcinomas with a low DNA index [14] .
The purpose of the study is to evaluate, if an assessing of the malignancy of hepataocellular aarcinomas in cirrhosis using MRI with hepatocellular contrast agent will be possible.
Patients and Methods
Sixty-three patients with histologically proofed HCC in cirrhosis who underwent MRI of the liver with the heaptocellular MR contrast agent Gd-EOB-DTPA were retrospectively included in the study. All of them underwent resection or liver transplant. The patients had a mean age of 63.0 ± 10.0 years (52 men, 64.0 ± 8.5 years, range 43 -84; 11 women, 58.3 ± 14.9 years, range 32 -82). Pathohistologic grading of the patients included in the study yielded 26 well differentiated (G1), 28 moderately differentiated (G2), and 8 poorly differentiated HCCs (G3). In one HCC, the degree of differentiation could not be determined (GX).
DNA Cytometry
The DNA content determined by means of these nuclei singlecellabsorptionphotometry. The measurement was carried out in the fine-scanning method using a microscope cytophotometer (Ahrens Medical Supply Tecnic, argteheide, Germany). The control of the scanning table, the measuring process and the registration of the absorption programmatically were effected by process computer. The measured data of the respective total extinktion were printed along with the mean, standard deviation, variance and coefficient of variation through a telephoto type. The measurement of the integrated optical density of nuclei is coupled interactive on the monitor of a conventional microscope with a PC-based TV image analysis system. The microscope is equipped with a color TV camera and appropriate interference filters. Within the relevant cell population of at least 300 cell nuclei are measured randomly assigned. The measurement is done automatically by clicking the relevant nuclei with a mouse on the screen. A DNA histogram. determined per measurement DNA content of about 300 cell nuclei is combined in a cytophotogramm and as an absolute value in AU (arbitraryunits) specified. The number of cytomorphometric nuclei measured is denoted by "n". The determination of the 2 c value, i.e., of the DNA-content corresponding to a normal diploid set of chromosomes occurs in lymphocytes or leukocytes as a calibration diploid cell population. The so-called standard cells (standard calibration cell population) have to be set in the same manner as the measured nuclei of the hepatocytes Hepatozytenkerne, hydrolyzed and stained according to 
MRI-Examination
MRI examinations were performed on a 1.5-Tesla Genesis Signa MR scanner (General Electric Medical Systems, Wisconsin, USA) using an 8-channel surface receive only coil. The following pulse sequences were analyzed:  Native breath-hold T1-weighted 2D gradient echo 

The fact that only these two asymmetry coefficients could be calculated is due to the pulse sequences that were available for analysis: Postcontrast images in the arterial and venous phase were acquired with the T1-weighted 3D sequence, while nonenhanced images and the late venous phase were acquired using the T1-weighted 2D sequence. This is why no asymmetry coefficients could be calculated for nonenhanced SI and the arterial phase or for the arterial or venous phase and the late venous phase.
The standardized signal intensities, I, of HCCs determined from the above-described sequences and the two asymmetry coefficients (AC art-ven , AC late-ven ) were correlated with histopathologic grades in all 63 patients and with the cytometric DNA index in 52 patients.
Results
Analysis by degree of HCC differentiation did not reveal any significant correlations for the standardized signal intensities on the unenhanced pulse sequences and the cytometric DNA index for any of the groups. The same was true for the standardized signal intensities measured on the contrast-enhanced images and their correlation with the DNA indices for any of the pathohistologic HCC grades.
With increasing DNA indices, we saw a tendency for higher standardized signal intensities in the arterial phase and for lower standardized signal intensities in the venous phase.
In contrast, significant correlations were found for AC art-ven and the DNA index using both Pearson's correlation analysis (linear) (p = 0.00089) and the Spearman rho (nonlinear) (p = 0.0082). The second asymmetry index investigated, AC pre-late-ven , did not significantly correlate with the DNA index (p = 0.67; p = 0.40). No significant correlation of the asymmetry index with the tumor grade was found.
The Figures 4 and 5 illustrate the relationships between the two asymmetry coefficients, AC art-ven and AC pre-late-venous , and the DNA index.
Discussion
We found no correlation between the MR signal intensities of HCCs on the pulse sequences investigated and the tumor stage or cytometric DNA index for nonenhanced images or the arterial, venous, or late venous phases of the dynamic series; however, we saw a tendency for increasing DNA indices to be associated with higher standardized signal intensities in the arterial phase and lower intensities in the venous phase. In contrast, we found a significant correlation between asymmetry coefficient AC art-ven and the DNA index but not for the second asymmetry coefficient we investigated, i.e., the one between signal intensities on unenhanced images and those measured in the late venous phase. These results suggest that the malignant potential of HCC, expressed in the DNA index, increases with an increasing difference in standardized signal intensities between the arterial and venous phases, as indicated by increasing values of asymmetry coefficient AC art-ven .
In terms of function, this means that strong arterializetion of a tumor with rapid washout in the venous phase corresponds to a higher DNA index and hence a higher malignant potential. Conversely, a lower value for AC art-ven corresponds to a lower DNA index or malignant poten-R. RÖTTGEN ET AL.
tial.
We attribute this result to the assumption that a high malignant potential, as indicated by a high DNA index, is associated with enhanced angiogenesis and results in tumors with a larger number of arteries and veins. This assumption would explain the stronger arterial and weaker venous enhancement we saw in tumors with a high DNA index, as opposed to those with a lower DNA index. The presence of more vessels in a tumor means that contrast medium inflow and outflow is both faster and more pronounced.
Conversely, our initial hypothesis that contrast-enhanced MRI using Gd-EOB-DTPA would also improve the characterization of HCC in cirrhosis with regard to histopathological tumor grades was not confirmed here. We found no statistically significant associations between standardized signal intensities in the arterial, venous and late phases of the dynamic contrast-enhanced series and the histopathologic tumor grade. This disappointing outcome might also in part be due to the fact that HCC is a heterogeneous group with mixed types and overlap between the different histological grades, making it difficult at times to assign a tumor to a specific histologic grade.
Based on the results presented here, the dynamic contrast behavior of HCC might supplement preoperative MRI, providing useful diagnostic information that goes beyond the Milan criteria in evaluating candidates for liver transplant. Enhancement patterns might provide clues about the malignant potential and the prognosis that cannot be derived from merely evaluating the morphologic imaging appearance of HCC. It might also be speculated that our results on the potential role of con-trast enhancement also apply to other, nonspecific contrast agents.
Imaging detection of HCC in cirrhosis has been investtigated in many studies [1, [15] [16] [17] [18] [19] [20] . Schneider et al. and Hentrich et al. demonstrated the significance of contrast-enhanced dynamic MRI using the hepatobiliary contrast agent Gd-BOPTA (Multi-Hance®) for the detection and differentiation of benign and malignant hepatic lesions [21] . Hentrich et al. showed that late enhancement is related to cellular differentiation with moderately differentiated HCC exhibiting significantly stronger uptake of contrast medium than poorly differentiated HCC. Horigome et al. compared MRI including dynamic contrast-enhanced imaging using Gd-DTPA (Magnevist®) with the histopathologic grades of tumor differenttiation and showed that detection by MRI improves with poorer differentiation and larger tumor size [22] . Jonas et al. investigating patients who received a liver transplant for HCC identified DNA ploidy as a valuable prognostic factor that is superior to tumor stage and other prognostic factors. In this study of patients who received a liver transplant because of HCC, aneuploidy indicated a poorer prognosis compared with diploid or polyploid HCCs [23] . In a univariate analysis, the same study group also identified the cytometric DNA index as a prognostic parameter in liver transplant recipients after HCC in cirrhosis in addition to the Milan criteria, the histopathologic tumor grade, vascular invasion, and the cytometric DNA index. A multivariate analysis identified the DNA index and vascular invasion as prognostic parameters [10] .
The Milan criteria, which are used as a basis for selecting patients with HCC in cirrhosis for liver transplantation, take into account the number and size of lesions. In addition, information on differentiation and malignancy of an HCC would be also useful. Liver transplant recipients meeting the Milan criteria have a mean 5-year survival rate of 62% to 70% when the degree of differentiation of HCC is not taken into account. Patients not meeting these criteria have poorer survival rates. Several histopathologic studies of explanted livers revealed microvascular tumor invasion as an independent negative predictor of survival after liver transplant. These studies also showed a significantly higher incidence of microvascular invasion with increasing tumor size [11, 24, 25] . The risk of microvascular invasion is greater than 50% for patients with HCC > 5 cm.
Other factors, apart from the Milan criteria, that have been found to influence survival are the histopathologic tumor grade, vascular invasion, and DNA cytometry (DNA ploidy, DNA index) [10, 11, 23, 25] . The signifycant association we found between the arterial-venous asymmetry coefficient, i.e., the ratio of contrast enhancement in the arterial phase to that in the venous phase, and the DNA index suggests that a dynamic MRI study of the liver using the hepatocellular contrast agent Gd-EOB-DTPA provides information on malignancy or the biological aggressiveness of HCC. Used in patients with HCC in cirrhosis, this asymmetry coefficient might provide supplementary information for selecting the surgical procedure (extent of resection/liver transplant) or serve as a prognostic factor.
Additional studies-ideally in larger patient populations-are needed to confirm our findings. The Milan criteria might then be supplemented by the preoperatively determined MRI criterion of the asymmetry coefficient describing the ratio of arterial enhancement to venous washout following administration of a hepatocytic contrast agent.
Summary
Our study investigating signal intensities and asymmetry coefficients determined from preoperative MR images obtained using the hepatocellular contrast agent Gd-EOB-DTPA in patients with hepatocellular carcinoma and cirrhosis revealed a statistically significant relation-ship between the asymmetry coefficient of signal enhancement in the arterial and venous phases and the cancer's malignant potential as reflected in the DNA index. The asymmetry coefficient thus has the potential to enable preoperative assessment of the malignant potential of HCC and its prognosis. Preoperative assessment of the malignancy or aggressiveness of HCC using this MRI asymmetry coefficient might be a useful supplement to other imaging criteria such as lesion size, number, and site.
